This one’s a little off-topic… technically it’s nothing to do with psychedelics.
You might have heard of kratom recently; it’s been in the news quite a bit, since the DEA announced in August that they wanted to make it illegal, before they fairly quickly withdrew their plans in the face of a loud public backlash. After all, thousands of Americans have been using kratom to combat prescription drug addiction or alcoholism – getting rid of kratom could cause huge damage to people’s lives.
Kratom is a plant that grows almost everywhere in SouthEast Asia. Its leaves are traditionally chewed for their sedative and painkilling properties. In the West, it’s often found in dried form, and brewed into a tea or swallowed in capsules. Kratom contains a bunch of alkaloids that have a relaxing and soothing effect. It’s like a plant-based alcohol – except, it hasn’t been directly linked to seven forms of cancer, like alcohol has.
Compassion is not the first thing that comes to mind when we think of economics or the stock market. Modern economics is more often a negative force than a positive one. Debt, bribery, greed and corruption are always associated with money – values like love and empathy… not so much.
Does this make money automatically a bad thing? Maybe money is just a necessary evil, maybe economics is the crumbling foundation on which we must build our extravagant society.
But maybe it doesn’t have to be that way. What if we could create a form of economics that didn’t create debt, but negated it? What if we lived in a world with a compassionate currency that rewarded good deeds rather than greed?
Psychedelics can treat depression. They can treat anxiety, they can help you quit smoking, they can help recovering alcoholics and they can treat cluster headaches.
But these classic psychedelics, LSD and psilocybin, can also have a nasty bite. ‘Bad trips’ have been publicised since the psychedelic culture of the 60s, including (often fabricated) tales of people jumping off buildings or staring at the sun until blind. But it’s a reality that powerful psychedelic drugs can cause traumatic experiences if not used correctly.
In the most recent edition of the Journal of Psychopharmacology, Professor David Nutt introduces two new studies that add to the growing body of evidence suggesting that psilocybin can be used to help people with anxiety or depression related to terminal illness. It’s all exciting stuff, is already being covered by major news outlets, and will no doubt help to further the cause of the psychedelic reform movement.
Psilocybin is helping people with terminal illnesses accept death
Included in the issue is a paper about ‘challenging experiences’ people encounter when using psilocybin outside of a clinical setting. It’s an interesting contrast to the unrestrained positive message we’ve been hearing about psilocybin in recent studies. Here, the authors point out that of nearly 2000 recorded ‘bad trips’, around 50 resulted in physical violence or hospitalisation. 152 of those surveyed felt they needed treatment for the long-term psychological effects of the experience, and three people attempted suicide.